Early Recognition of Acute Kidney Injury: What’s the Role of Biomarkers? - a podcast by ReachMD

CME credits: 0.25

Valid until: 30-06-2021

Claim your CME credit at https://reachmd.com/programs/cme/early-recognition-of-acute-kidney-injury-whats-the-role-of-biomarkers/11222/

Acute kidney injury (AKI) is a common problem faced by both nephrologists and intensivists as well as surgeons and general practitioners. AKI is increasing in hospitalized patients, and since it’s associated with both short- and long-term adverse outcomes, early recognition of patients who are at an increased risk for developing AKI is essential if we are to effectively intervene and provide optimal outcomes. Fortunately, recent data suggests that certain biomarkers can help us in clinical decision making with regard to AKI—which is the focus of this discussion.

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD